Morgan Stanley Sees Possible Benefits For CyrusOne

Loading...
Loading...
In a report published Monday, Morgan Stanley analyst Simon Flannery reiterated an Overweight rating and $25.00 price target on
CyrusOneCONE
. In the report, Morgan Stanley noted, “A partial CBB share placement could benefit the CONE stock price by increasing liquidity and addressing the overhang issue. Recent meetings with CBB management reinforce our view that they will look to place some of the stake in a timely manner but only at appropriate valuations.” CyrusOne closed on Friday at $22.88.
Posted In: Analyst ColorReiterationAnalyst RatingsMorgan StanleySimon Flannery
We simplify the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...